Patient Leaflet Updated 04-Oct-2024 | Clinigen Healthcare Ltd
Mexiletine Hard Capsules
Mexiletine Hard Capsules
(Mexiletine hydrochloride 50 mg Hard Capsules)
(Mexiletine hydrochloride 100 mg Hard Capsules)
(Mexiletine hydrochloride 200 mg Hard Capsules)
Mexiletine hydrochloride
The name of your product is Mexiletine hydrochloride 50 mg, 100 mg or 200 mg Hard Capsules, but it will be referred to as Mexiletine Hard Capsules throughout this leaflet.
There is an Alert Card distributed with Mexiletine Hard Capsules, to remind you and medical staff of the risk of cardiac arrhythmias. Read the Alert Card in conjunction with this leaflet and keep the card with you at all times.
1. What Mexiletine Hard Capsules is and what it is used for
2. What you need to know before you take Mexiletine Hard Capsules
3. How to take Mexiletine Hard Capsules
4. Possible side effects
5. How to store Mexiletine Hard Capsules
6. Contents of the pack and other information
Mexiletine Hard Capsules is a medicine that contains the active substance mexiletine hydrochloride.
Mexiletine Hard Capsules are indicated for the documented irregular heartbeat which, in the judgement of the physician, is considered as life-threatening.
Talk to your doctor or pharmacist or nurse before taking Mexiletine Hard Capsules:
Mexiletine Hard Capsules should not be used in children and adolescents younger than 18 years old.
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines.
Tell your doctor or pharmacist if you are taking any of the following since these medicines may affect or be affected by Mexiletine Hard Capsules:
Tell your doctor or pharmacist if you start to smoke or quit smoking while taking Mexiletine Hard Capsules because smoking impacts the Mexiletine blood levels and your dose may need to be adjusted accordingly.
It is recommended to take mexiletine after food in order to reduce the incidence of gastrointestinal adverse effects.
It is recommended to reduce your caffeine intake by half while on treatment with mexiletine because the medicine can increase caffeine levels in your blood.
Limit the amount of alcohol you drink while taking this medicine.
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby ask your doctor or pharmacist for advice before taking any medicine.
As a precautionary measure, it is preferable to avoid the use of mexiletine during pregnancy. Mexiletine appears in human milk, if your doctor decides to give you Mexiletine you will need to consider an alternative method of feeding your baby.
The effects of mexiletine on fertility in humans have not been studied.
This medicine can affect your ability to drive and operate machinery. Do not drive or operate machinery while taking this medicine, until you know how it affects you. Talk to your doctor or pharmacist if you are not sure whether it is safe for you to drive while taking this medicine.
These medicines contain less than 1 mmol sodium (23 mg) per capsule, that is to say essentially ‘sodium-free’.
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor or pharmacist if you are not sure.
Your doctor may ask you to start therapy with a dose of 400 mg (2 capsules of 200 mg).
The maintenance dose is 150 mg (1 capsule of 50 mg plus 1 capsule of 100 mg) to 300 mg (1 capsule of 100 mg plus 1 capsule of 200 mg) given two to three times daily.
If necessary, dose may be adjusted in 50 or 100 mg increments. A minimum of two to three days between dose adjustments is recommended.
The dose should not exceed 1200 mg per day (6 capsules of 200 mg).
In some cases, your doctor may then decide to either increase or lower the amount you take each day. This will depend on how you react to this medicine.
Mexiletine capsules should not be given to children and adolescents.
Mexiletine should be used with caution in patients with mild or moderate liver dysfunction. In those patients, a minimum of two weeks between dose adjustments is recommended. Mexiletine should not be used in patients with severe liver disease.
In patients with mild-to-moderate kidney disease no adjustment of the starting dose is required. Mexiletine should not be used in patients with severe kidney disease.
Dose adjustments may be needed if you have a genetic problem with an enzyme in your body called CYP2D6. A minimum of one week between dose adjustments is recommended.
Contact your doctor if you take more than the recommended dose of Mexiletine Hard Capsules. This could be very harmful to your health. You or your companion should contact the doctor immediately if you have nausea, hypotension (low blood pressure), bradycardia (slow heartbeat), paraesthesia (tingling of the extremities), if you have hallucinations (seeing or hearing something that is not present), convulsions (fits), if you feel that your heart beats irregularly (slower or faster), if you collapse or if your heart stops beating.
Take the next dose as soon as you remember unless it is almost time for your next dose. Do not take a double dose to make up for a forgotten dose.
If you have further questions on the use of this medicine, ask your doctor or pharmacist.
If you suddenly stop taking Mexiletine you may experience side effects. Speak to your doctor first before stopping this medicine. If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Contact your doctor or go to your nearest emergency center immediately if you experience any of the following side effects:
Contact your doctor or pharmacist if you experience any of the following side effects:
Very common side effects (may affect more than 1 in 10 people):
Common side effects (may affect up to 1 in 10 people):
Uncommon side effects (may affect up to 1 in 100 people):
Rare side effects (may affect up to 1 in 1,000 people):
Very rare side effects (may affect up to 1 in 10,000 people):
Not known (frequency cannot be estimated from the available data):
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme at www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and blister after EXP. The expiry date refers to the last day of that month.
Store below 30°C.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
Mexiletine hydrochloride 50 mg Hard Capsules
Mexiletine hydrochloride 100 mg Hard Capsules
Mexiletine hydrochloride 200 mg Hard Capsules
Mexiletine hydrochloride 50 mg Hard Capsules are size 4, opaque hard gelatin capsules of white body and white cap.
Mexiletine hydrochloride 100 mg Hard Capsules are size 3, opaque hard gelatin capsules of white body and light blue cap.
Mexiletine hydrochloride 200 mg Hard Capsules are size 1, opaque hard gelatin capsules of light blue body and light blue cap.
They are packed in PVC/PVDC/aluminium blisters. Each blister contains 10 or 14 capsules.
Pack sizes: 30, 50, 56, 84, 100, 200 hard capsules.
Not all pack sizes may be marketed.
Marketing Authorisation Holder
Manufacturer
This leaflet was last revised in June 2024.
Pitcairn House, First Avenue, Burton-on-Trent, DE14 2WW, UK
+44 (0)1283 494341
+44 (0)1283 494340
+44 (0)1932 555 026
http://www.clinigengroup.com